中华皮肤科杂志 ›› 2024, Vol. 57 ›› Issue (5): 400-408.doi: 10.35541/cjd.20230603
《乳房外Paget病诊治专家共识（2024版）》编写委员会专家组
收稿日期:2023-10-23
修回日期:2024-01-18
发布日期:2024-04-30
通讯作者:
陈翔；商冠宁;陈嵘祎
E-mail:chenxiangck@126.com;shgn1975@163.com;rongyichen@163.com
基金资助:Writing Committee Expert Group on “Treatment of Extramammary Paget′s Disease: a Chinese Expert Consensus Statement （2024）”
Received:2023-10-23
Revised:2024-01-18
Published:2024-04-30
Contact:
Chen Xiang; Shang Guanning; Chen Rongyi
E-mail:chenxiangck@126.com;shgn1975@163.com;rongyichen@163.com
Supported by:摘要： 【摘要】 乳房外Paget病是一种少见且易误诊的皮肤恶性肿瘤，其早期病变局限于表皮，也可浸润至真皮层，晚期则可能出现淋巴结转移和远处转移。乳房外Paget病常见于大汗腺分布区域，包括阴囊、阴茎、外阴以及肛周、腹股沟、腋窝等部位，常表现为红色斑片或浸润性斑块，部分皮损伴有鳞屑、糜烂等。在选择治疗方案前，必须对患者进行全面的分期评估。本专家共识基于国际上最新的指南和临床研究成果，结合我国的临床治疗实践，形成了关于乳房外Paget病分期治疗的一线和二线治疗方案以及新型治疗方法，为规范乳房外Paget病的治疗提供依据。
《乳房外Paget病诊治专家共识（版）》编写委员会专家组. [开放获取] 乳房外Paget病诊治专家共识（2024版）[J]. 中华皮肤科杂志, 2024,57(5):400-408. doi:10.35541/cjd.20230603
Writing Committee Expert Group on “Treatment of Extramammary Paget′s Disease: a Chinese Expert Consensus Statement （）”. Treatment of extramammary Paget′s disease: a Chinese expert consensus statement （2024）[J]. Chinese Journal of Dermatology, 2024, 57(5): 400-408.doi:10.35541/cjd.20230603
| ［1］ | Elder DE, Massi D, Scolyer RA, et al. WHO classification of skin tumours［M］. 4th ed. Lyon: IARC Press, 2018. |
| ［2］ | Yin S, Xu L, Wang S, et al. Prevalence of extramammary Paget′s disease in urban China: a population⁃based study［J］. Orphanet J Rare Dis, 2021,16（1）:134. doi: 10.1186/s13023⁃021⁃01715⁃6. |
| ［3］ | van der Zwan JM, Siesling S, Blokx WA, et al. Invasive extramammary Paget′s disease and the risk for secondary tumours in Europe［J］. Eur J Surg Oncol, 2012,38（3）:214⁃221. doi: 10.1016/j.ejso.2011.12.008. |
| ［4］ | Ghazawi FM, Iga N, Tanaka R, et al. Demographic and clinical characteristics of extramammary Paget′s disease patients in Japan from 2000 to 2019［J］. J Eur Acad Dermatol Venereol, 2021,35（2）:e133⁃e135. doi: 10.1111/jdv.16868. |
| ［5］ | OCEBM Levels of Evidence Working Group. “The Oxford Levels of Evidence 2”. Oxford Centre for Evidence⁃Based Medicine［EB/OL］. 2011. https://www.cebm.ox.ac.uk/resources/levels⁃of⁃evidence/ocebm⁃levels⁃of⁃evidence. |
| ［6］ | Regauer S. Extramammary Paget′s disease — a proliferation of adnexal origin?［J］. Histopathology, 2006,48（6）:723⁃729. doi: 10.1111/j.1365⁃2559.2006.02405.x. |
| ［7］ | Zhang G, Zhou S, Zhong W, et al. Whole⁃exome sequencing reveals frequent mutations in chromatin remodeling genes in mammary and extramammary Paget′s diseases［J］. J Invest Dermatol, 2019,139（4）:789⁃795. doi: 10.1016/j.jid.2018.08.030. |
| ［8］ | Kajtezovic S, Walker AR, Hjalmarsson B, et al. Management of secondary Paget′s disease of the vulva associated with transitional cell carcinoma［J］. J Cancer Res Clin Oncol, 2022,148（7）:1697⁃1702. doi: 10.1007/s00432⁃022⁃04007⁃z. |
| ［9］ | Lam C, Funaro D. Extramammary Paget′s disease: summary of current knowledge［J］. Dermatol Clin, 2010,28（4）:807⁃826. doi: 10.1016/j.det.2010.08.002. |
| ［10］ | 王光平, 李燕, 王惠平, 等. 硬化萎缩性苔藓样乳房外Paget病1例［J］. 中华皮肤科杂志, 2023,56（4）:346⁃347. doi: 10.35541/cjd.20201233. |
| ［11］ | Ishizuki S, Nakamura Y. Extramammary Paget′s disease: diagnosis, pathogenesis, and treatment with focus on recent developments［J］. Curr Oncol, 2021,28（4）:2969⁃2986. doi: 10. 3390/curroncol28040260. |
| ［12］ | Morris CR, Hurst EA. Extramammary Paget disease: a review of the literature⁃part i: history, epidemiology, pathogenesis, presentation, histopathology, and diagnostic work⁃up［J］. Dermatol Surg, 2020,46（2）:151⁃158. doi: 10.1097/DSS.0000000000002064. |
| ［13］ | Simonds RM, Segal RJ, Sharma A. Extramammary Paget′s disease: a review of the literature［J］. Int J Dermatol, 2019,58（8）:871⁃879. doi: 10.1111/ijd.14328. |
| ［14］ | Ito T, Kaku⁃Ito Y, Furue M. The diagnosis and management of extramammary Paget′s disease［J］. Expert Rev Anticancer Ther, 2018,18（6）:543⁃553. doi: 10.1080/14737140.2018.1457955. |
| ［15］ | Cho WC, Ding Q, Wang WL, et al. Immunohistochemical expression of TRPS1 in mammary Paget disease, extramammary Paget disease, and their close histopathologic mimics［J］. J Cutan Pathol, 2023,50（5）:434⁃440. doi: 10.1111/cup.14414. |
| ［16］ | Taniguchi K, Goto K, Yabushita H, et al. Transcriptional repressor GATA binding 1 （TRPS1） immunoexpression in normal skin tissues and various cutaneous tumors［J］. J Cutan Pathol, 2023,50（11）:1006⁃1013. doi: 10.1111/cup.14523. |
| ［17］ | Liu YA, Collins K, Aung PP, et al. TRPS1 expression in primary and secondary extramammary Paget diseases: an immunohisto⁃chemical analysis of 93 cases［J］. Hum Pathol, 2024,143:5⁃9. doi: 10.1016/j.humpath.2023.11.004. |
| ［18］ | Nakamura Y, Tanese K, Hirai I, et al. Serum cytokeratin 19 fragment 21⁃1 and carcinoembryonic antigen combination assay as a biomarker of tumour progression and treatment response in extramammary Paget disease［J］. Br J Dermatol, 2019,181（3）:535⁃543. doi: 10.1111/bjd.17789. |
| ［19］ | Kato J, Sumikawa Y, Hida T, et al. Serum cytokeratin 19 fragment 21⁃1 is a useful tumor marker for the assessment of extramammary Paget′s disease［J］. J Dermatol, 2017,44（6）:666⁃670. doi: 10.1111/1346⁃8138.13760. |
| ［20］ | Mijiddorj T, Kajihara I, Tasaki Y, et al. Serum cell⁃free DNA levels are a useful marker for extramammary Paget disease［J］. Br J Dermatol, 2019,181（3）:505⁃511. doi: 10.1111/bjd.17709. |
| ［21］ | Schmitt AR, Long BJ, Weaver AL, et al. Evidence⁃based screening recommendations for occult cancers in the setting of newly diagnosed extramammary Paget disease［J］. Mayo Clin Proc, 2018,93（7）:877⁃883. doi: 10.1016/j.mayocp.2018.02.024. |
| ［22］ | 张韡, 黄莉明, 聂瑾, 等. 皮肤镜在外阴部乳房外Paget病与慢性湿疹鉴别诊断中的意义［J］. 中华皮肤科杂志, 2019,52（9）:636⁃639. doi: 10.3760/cma.j.issn.0412⁃4030.2019.09.009. |
| ［23］ | Bayan CY, Khanna T, Rotemberg V, et al. A review of non⁃invasive imaging in extramammary Paget′s disease［J］. J Eur Acad Dermatol Venereol, 2018,32（11）:1862⁃1873. doi: 10.1111/ jdv.15072. |
| ［24］ | Komatsu⁃Fujii T, Nomura T, Kaku Y, et al. In vivo identification of tumor cells of the basal layer of the epidermis in an early lesion of extramammary Paget disease: a reflectance confocal microscopic analysis［J］. JAAD Case Rep, 2021,11:12. doi: 10.1016/j.jdcr.2021.02.026. |
| ［25］ | 国家皮肤与免疫疾病临床医学研究中心, 中国医师协会皮肤科医师分会皮肤外科亚专业委员会, 中国中西医结合学会皮肤性病学专业委员会皮肤影像学组, 等. 常见皮肤病高频皮肤超声诊断专家共识［J］. 中国医学前沿杂志（电子版）, 2019,11（8）:23⁃28. doi: 10.12037/YXQY.2019.08⁃04. |
| ［26］ | Okumura M, Ogata D, Namikawa K, et al. Postoperative radiation therapy improves prognoses in extramammary Paget′s disease presenting with multiple lymph node metastases［J］. J Dermatol, 2022,49（10）:1005⁃1011. doi: 10.1111/1346⁃8138. 16491. |
| ［27］ | Ogata D, Kiyohara Y, Yoshikawa S, et al. Usefulness of sentinel lymph node biopsy for prognostic prediction in extramammary Paget′s disease［J］. Eur J Dermatol, 2016,26（3）:254⁃259. doi: 10.1684/ejd.2016.2744. |
| ［28］ | Ohara K, Fujisawa Y, Yoshino K, et al. A proposal for a TNM staging system for extramammary Paget disease: retrospective analysis of 301 patients with invasive primary tumors［J］. J Dermatol Sci, 2016,83（3）:2349. doi: 10.1016/j.jdermsci.2016. 06.004. |
| ［29］ | Amin MB, Edge S, Greene F, et al. AJCC cancer staging manual［M］. 8th ed. New York, NY: Springer, 2017. |
| ［30］ | Nasioudis D, Bhadra M, Ko EM. Extramammary Paget disease of the vulva: management and prognosis［J］. Gynecol Oncol, 2020,157（1）:146⁃150. doi: 10.1016/j.ygyno.2019.11.009. |
| ［31］ | Hatta N, Yamada M, Hirano T, et al. Extramammary Paget′s disease: treatment, prognostic factors and outcome in 76 patients［J］. Br J Dermatol, 2008,158（2）:313⁃318. doi: 10.1111/j.1365⁃2133.2007.08314.x. |
| ［32］ | Kibbi N, Owen JL, Worley B, et al. Evidence⁃based clinical practice guidelines for extramammary Paget disease［J］. JAMA Oncol, 2022,8（4）:618⁃628. doi: 10.1001/jamaoncol.2021.7148. |
| ［33］ | Kaku⁃Ito Y, Ito T, Tsuji G, et al. Evaluation of mapping biopsies for extramammary Paget disease: a retrospective study［J］. J Am Acad Dermatol, 2018,78（6）:1171⁃1177.e4. doi: 10.1016/j.jaad.2017.12.040. |
| ［34］ | Kato T, Fujimoto N, Fujii N, et al. Mapping biopsy with punch biopsies to determine surgical margin in extramammary Paget′s disease［J］. J Dermatol, 2013,40（12）:968⁃972. doi: 10.1111/1346⁃8138.12347. |
| ［35］ | Kim GY, Campbell EH, Brewer JD. Local recurrence rates of extramammary Paget disease are lower after Mohs micrographic surgery compared with wide local excision: a systematic review and meta⁃analysis［J］. Dermatol Surg, 2023,49（1）:8⁃12. doi: 10.1097/DSS.0000000000003601. |
| ［36］ | Bae JM, Choi YY, Kim H, et al. Mohs micrographic surgery for extramammary Paget disease: a pooled analysis of individual patient data［J］. J Am Acad Dermatol, 2013,68（4）:632⁃637. doi: 10.1016/j.jaad.2012.12.960. |
| ［37］ | Long B, Schmitt AR, Weaver AL, et al. A matter of margins: surgical and pathologic risk factors for recurrence in extramammary Paget′s disease［J］. Gynecol Oncol, 2017,147（2）:358⁃363. doi: 10.1016/j.ygyno.2017.09.008. |
| ［38］ | 万苗坚, 马寒, 龚子鉴, 等. 周围组织的 Mohs 显微描记外科手术治疗乳房外Paget病［J］. 中华皮肤科杂志, 2016,49（4）:278⁃280. doi: 10.3760/cma.j.issn.0412⁃4030.2016.04.012. |
| ［39］ | 孔令卓, 张韡, 单士军, 等. 反射式共聚焦显微镜辅助手术治疗外阴乳房外Paget病二例［J］. 中华皮肤科杂志, 2021,54（8）:723⁃725. doi: 10.35541/cjd.20180711. |
| ［40］ | Wu M, Huang L, Lu X, et al. Utility of photodynamic diagnosis plus reflectance confocal microscopy in detecting the margins of extramammary Paget disease［J］. Indian J Dermatol Venereol Leprol, 2021,87（2）:207⁃213. doi: 10.25259/IJDVL_90_20. |
| ［41］ | Navarrete⁃Dechent C, Aleissa S, Cordova M, et al. Treatment of extramammary Paget disease and the role of reflectance confocal microscopy: a prospective study［J］. Dermatol Surg, 2021,47（4）:473⁃479. doi: 10.1097/DSS.0000000000002934. |
| ［42］ | Dengel L, Turza K, Noland MM, et al. Skin mapping with punch biopsies for defining margins in melanoma: when you don′t know how far to go［J］. Ann Surg Oncol, 2008,15（11）:3028⁃3035. doi: 10.1245/s10434⁃008⁃0138⁃1. |
| ［43］ | Huang SW, Wang ST, Chang SH, et al. Imiquimod exerts antitumor effects by inducing immunogenic cell death and is enhanced by the glycolytic inhibitor 2⁃deoxyglucose［J］. J Invest Dermatol, 2020,140（9）:1771⁃1783.e6. doi: 10.1016/j.jid.2019. 12.039. |
| ［44］ | van der Linden M, van Hees CL, van Beurden M, et al. The Paget trial: topical 5% imiquimod cream for noninvasive vulvar Paget disease［J］. Am J Obstet Gynecol, 2022,227（2）:250.e1⁃250.e8. doi: 10.1016/j.ajog.2022.04.012. |
| ［45］ | Snast I, Sharon E, Kaftory R, et al. Nonsurgical treatments for extramammary Paget disease: a systematic review and meta⁃analysis［J］. Dermatology, 2020,236（6）:493⁃499. doi: 10.1159/000506832. |
| ［46］ | Machida H, Moeini A, Roman LD, et al. Effects of imiquimod on vulvar Paget′s disease: a systematic review of literature［J］. Gynecol Oncol, 2015,139（1）:165⁃171. doi: 10.1016/j.ygyno.2015. 07.097. |
| ［47］ | Donohoe C, Senge MO, Arnaut LG, et al. Cell death in photodynamic therapy: from oxidative stress to anti⁃tumor immunity［J］. Biochim Biophys Acta Rev Cancer, 2019,1872（2）:188308. doi: 10.1016/j.bbcan.2019.07.003. |
| ［48］ | Gao Y, Zhang XC, Wang WS, et al. Efficacy and safety of topical ALA⁃PDT in the treatment of EMPD［J］. Photodiagnosis Photodyn Ther, 2015,12（1）:92⁃97. doi: 10.1016/j.pdpdt.2014.11.004. |
| ［49］ | 张良, 陈娜, 郑亮, 等. Mohs显微手术治疗乳房外Paget病42例［J］. 中国麻风皮肤病杂志, 2017,33（7）:410⁃412. |
| ［50］ | 叶文正, 李词娟, 吴一文, 等. Mohs手术联合光动力治疗乳房外Paget病的临床观察［J］. 中国美容医学, 2018,27（6）:4⁃7. |
| ［51］ | 王奕, 胡利萍, 廖程琦, 等. Mohs手术与光动力疗法单独或联合应用治疗乳房外Paget病疗效观察［J］. 中国美容医学, 2020,29（10）:61⁃64. |
| ［52］ | 张慧, 李光, 聂敏艳, 等. 荧光定位肿瘤边界并手术ALA⁃PDT治愈乳房外Paget病1例［J］. 中国医学文摘（皮肤科学）, 2015,32（2）:228⁃231. |
| ［53］ | 杨镓宁, 潘宁, 戴耕武, 等. Mohs显微描记手术联合光动力疗法治疗会阴部乳房外Paget病1例［J］. 实用皮肤病学杂志, 2013,6（1）:31⁃33. doi: 10.11786/sypfbxzz.1674⁃1293.20130113. |
| ［54］ | Shim PJ, Zeitouni NC. Photodynamic therapy for extramammary Paget′s disease: a systematic review of the literature［J］. Photodiagnosis Photodyn Ther, 2020,31:101911. doi: 10.1016/j.pdpdt.2020.101911. |
| ［55］ | Tolia M, Tsoukalas N, Sofoudis C, et al. Primary extramammary invasive Paget′s vulvar disease: what is the standard, what are the challenges and what is the future for radiotherapy?［J］. BMC Cancer, 2016,16:563. doi: 10.1186/s12885⁃016⁃2622⁃5. |
| ［56］ | Hata M, Koike I, Wada H, et al. Postoperative radiation therapy for extramammary Paget′s disease［J］. Br J Dermatol, 2015,172（4）:1014⁃1020. doi: 10.1111/bjd.13357. |
| ［57］ | Tagliaferri L, Casà C, Macchia G, et al. The role of radiotherapy in extramammary Paget disease: a systematic review［J］. Int J Gynecol Cancer, 2018,28（4）:829⁃839. doi: 10.1097/IGC.00000 00000001237. |
| ［58］ | Itonaga T, Nakayama H, Okubo M, et al. Radiotherapy in patients with extramammary Paget′s disease — our own experience and review of the literature［J］. Oncol Res Treat, 2014,37（1⁃2）:18⁃22. doi: 10.1159/000358161. |
| ［59］ | Hata M, Koike I, Wada H, et al. Radiation therapy for extramammary Paget′s disease: treatment outcomes and prognostic factors［J］. Ann Oncol, 2014,25（1）:291⁃297. doi: 10.1093/annonc/mdt478. |
| ［60］ | Molina GE, Khalifian S, Mull JL, et al. Topical combination of fluorouracil and calcipotriene as a palliative therapy for refractory extramammary Paget disease［J］. JAMA Dermatol, 2019,155（5）:599603. doi: 10.1001/jamadermatol.2018.4793. |
| ［61］ | Ferrara F, Bardazzi F, Messori S, et al. Photodynamic therapy following fractional CO2 laser for treatment of primary vulvar Paget′s disease: does it really work?［J］. J Dermatolog Treat, 2021,32（7）:800⁃802. doi: 10.1080/09546634.2019.1707755. |
| ［62］ | Fukui T, Watanabe D, Tamada Y, et al. Photodynamic therapy following carbon dioxide laser enhances efficacy in the treatment of extramammary Paget′s disease［J］. Acta Derm Venereol, 2009,89（2）:150⁃154. doi: 10.2340/00015555⁃0623. |
| ［63］ | Nakamura Y, Tanese K, Hirai I, et al. Weekly docetaxel monotherapy for metastatic extramammary Paget′s disease: retrospective single⁃institute analysis［J］. J Dermatol, 2020,47（4）:418⁃422. doi: 10.1111/1346⁃8138.15255. |
| ［64］ | Fukuda K, Hirai I, Nakamura Y, et al. S⁃1 in combination with docetaxel as salvage therapy for patients with metastatic extramammary Paget′s disease［J］. Eur J Dermatol, 2020,30（3）:301⁃302. doi: 10.1684/ejd.2020.3782. |
| ［65］ | Matsushita S, Fujii K, Kajihara I, et al. Efficacy of S⁃1 plus docetaxel in the treatment of metastatic extramammary Paget′s disease: a multicentre retrospective study［J］. Br J Dermatol, 2021,185（2）:458⁃460. doi: 10.1111/bjd.20135. |
| ［66］ | Tokuda Y, Arakura F, Uhara H. Combination chemotherapy of low⁃dose 5⁃fluorouracil and cisplatin for advanced extramammary Paget′s disease［J］. Int J Clin Oncol, 2015,20（1）:194⁃197. doi: 10.1007/s10147⁃014⁃0686⁃2. |
| ［67］ | Oashi K, Tsutsumida A, Namikawa K, et al. Combination chemotherapy for metastatic extramammary Paget disease［J］. Br J Dermatol, 2014,170（6）:1354⁃1357. doi: 10.1111/bjd.12788. |
| ［68］ | Angelico G, Santoro A, Inzani F, et al. Hormonal environment and HER2 status in extra⁃mammary Paget′s disease （eMPD）: a systematic literature review and meta⁃analysis with clinical considerations［J］. Diagnostics （Basel）, 2020,10（12）:1040. doi: 10.3390/diagnostics10121040. |
| ［69］ | Fukuda K, Funakoshi T. Metastatic extramammary Paget′s disease: pathogenesis and novel therapeutic approach［J］. Front Oncol, 2018,8:38. doi: 10.3389/fonc.2018.00038. |
| ［70］ | Sekiguchi N, Kubota S, Noguchi T, et al. Experiences of trastuzumab plus paclitaxel combination therapy in metastatic human epidermal growth factor receptor 2⁃positive extramammary Paget′s disease: four cases and a review［J］. J Dermatol, 2020,47（11）:1276⁃1279. doi: 10.1111/1346⁃8138.15515. |
| ［71］ | Mauzo SH, Tetzlaff MT, Milton DR, et al. Expression of PD⁃1 and PD⁃L1 in extramammary Paget disease: implications for immune⁃targeted therapy［J］. Cancers （Basel）, 2019,11（6）:754. doi: 10.3390/cancers11060754. |
| ［72］ | Guercio BJ, Iyer G, Kidwai WZ, et al. Treatment of metastatic extramammary Paget disease with combination ipilimumab and nivolumab: a case report［J］. Case Rep Oncol, 2021,14（1）:430⁃438. doi: 10.1159/000514345. |
| [1] | 中国“一带一路”皮肤病专病联盟分枝杆菌病研究联盟 中国麻风防治协会皮肤性病检验与诊断分会. [开放获取] 中国皮肤结核临床诊疗专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(5): 426-434. |
| [2] | 中国医师协会皮肤科医师分会 中国中西医结合学会皮肤性病学分会. 红皮病型银屑病诊疗中国专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(5): 409-417. |
| [3] | 中华医学会皮肤性病学分会 中国医师协会皮肤科医师分会 中国中西医结合学会皮肤性病专业委员会 . [开放获取] 中国化学剥脱术临床应用专家共识（公众版2024版）[J]. 中华皮肤科杂志, 2024, 0(5): 20230620-e20230620. |
| [4] | 中国医师协会皮肤科医师分会 中华医学会皮肤性病学分会 中国医疗保健国际交流促进会皮肤医学分会 疑难重症及罕见病国家重点实验室 国家皮肤与免疫疾病临床医学研究中心. 特应性皮炎治疗药物应用管理专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(2): 97-108. |
| [5] | 中国“一带一路”皮肤病专病联盟分枝杆菌病研究联盟 中国麻风防治协会皮肤性病检验与诊断分会. 中国皮肤非结核分枝杆菌病诊治专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(2): 109-118. |
| [6] | 中国中西医结合学会皮肤性病专业委员会皮肤肿瘤学组 中国抗癌协会黑色素瘤专业委员会. [开放获取] 人干扰素α1b治疗黑色素瘤专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(1): 1-7. |
| [7] | 岳超 王涛 段梦莹 戴叶芹 彭建中 沈忠 宋秀祖. 臀部双侧V-Y推进岛状皮瓣修复肛周Paget病术后缺损的应用[J]. 中华皮肤科杂志, 2024, 57(1): 58-61. |
| [8] | 中国医师协会皮肤科医师分会. [开放获取] 保湿润肤类产品应用指导专家共识（2023版）[J]. 中华皮肤科杂志, 2023, 56(8): 711-717. |
| [9] | 陈奇权 杨显杰 顾恒 徐金华 郝飞 姚煦 宋志强. [开放获取] 基于德尔菲法构建《中国慢性诱导性荨麻疹诊治专家共识（2023）》[J]. 中华皮肤科杂志, 2023, 56(6): 534-539. |
| [10] | 中华医学会皮肤性病学分会免疫学组. [开放获取] 中国慢性诱导性荨麻疹诊治专家共识（2023）[J]. 中华皮肤科杂志, 2023, 56(6): 479-488. |
| [11] | 中华医学会皮肤性病学分会 中国医师协会皮肤科医师分会. [开放获取] 慢性自发性荨麻疹达标治疗专家共识（2023）[J]. 中华皮肤科杂志, 2023, 56(6): 489-495. |
| [12] | 《蕈样肉芽肿治疗中国专家共识》编写专家组. [开放获取] 蕈样肉芽肿治疗中国专家共识（2023）[J]. 中华皮肤科杂志, 2023, 56(5): 402-409. |
| [13] | 中华医学会皮肤性病学分会 中国康复医学会皮肤病康复专业委员会 中国中西医结合学会皮肤性病学分会 中国医药教育协会皮肤病专业委员会. 老年带状疱疹诊疗专家共识[J]. 中华皮肤科杂志, 2023, 56(2): 97-104. |
| [14] | 丁玫琳 李弘扬 张韡 曾学思. 乳房外Paget病发病机制研究进展[J]. 中华皮肤科杂志, 2023, 0(2): 20220588-e20220588. |
| [15] | 中国研究型医院学会皮肤科学专业委员会 中国医师协会皮肤科医师分会. [开放获取] 慢性光化性皮炎诊疗专家共识（2023版）[J]. 中华皮肤科杂志, 2023, 56(12): 1096-1106. |
|
